Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study
People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s ...
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...
Nasdaq7d
How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study
Wegovy, however, has an edge over Zepbound in ... than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention.
The Hill8d
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from ...
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
The Independent9d
Weight loss drug battle heats up as Wegovy beaten in head-to-head trial
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...
AOL8d
Zepbound Leads to More Weight Loss Than Wegovy in Head-to-Head Clinical Trial
Zepbound affects two hormone receptors (Wegovy affects one ... “The challenge we face right now is being able to give patients access to any medication. Insurance coverage is extremely ...
Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo ...